Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Shares withheld for taxes President and CEO gave up 83,305 shares (to pay taxes)
  2. 4 Gift 10% owner gave 40,000 shares (gift)
  3. 4 Open-market sale Chief Operating Officer sold 44 shares at $4.87 ($214)
  4. 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 9,645 shares (to pay taxes)
  5. 4/A Shares withheld for taxes Chief Science Officer gave up 19,505 shares (to pay taxes)
  6. 4/A Shares withheld for taxes President and CEO gave up 56,824 shares (to pay taxes)
  7. 4/A Shares withheld for taxes SVP, Operations gave up 14,120 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Medical Officer gave up 10,819 shares (to pay taxes)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 3/A Insider 3/A
  16. 4 Grant or award SVP Sales and Marketing acquired 25,000 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Chief Science Officer acquired 10,000 shares (grant or award)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 5 of 17 · 326 filings